asgct

Welcome to ASGCT: Who We Are and What We Do

Congressional Briefing: How Gene Therapies are Transforming the Hemophilia Landscape

ASGCT 2023 Presentation Overview

Policy and Advocacy Shorts with Ashley Hume

Welcome to ASGCT: Become a Member

ASGCT 2024 Abstract Highlights with Chris Leidli, Emily Walsh Martin, and Lynnea Olivarez

ASGCT Recap 2023

Recent CMC Guidance for Cellular and Gene Therapies: BIO-ASGCT CGT Science Series

Lunch & Learn: Gene Therapy 101

ASGCT 2022 Presentation Preview

ASGCT: The Home of Cell and Gene Therapy

ASGCT 2024 Poster Presentations

ASGCT CEO David Barrett at #ASGCT22

What's it Like to Attend the ASGCT Annual Meeting?

Gene Editing Technologies: Transforming Rare Disease Care

Myrtelle ASGCT Symposium Presentations

Gene Therapy Basics (2022 Update)

SCID Immunodeficiency Trial - Brian Sorrentino

CRISPR Editing and AAV Integration in the Brain with Drs. Beverly Davidson and Bryan Simpson—The ...

Completing Your Profile and Networking at #ASGCT21

Biotech Discovery Labs: ASGCT + Milwaukee Public Schools

Around the World: Australasian Gene and Cell Therapy Society (AGCTS)

Clinical Gene Therapy: ASGCT Indo-UK Symposium

Welcome to the Annual Meeting with ASGCT President Jeff Chamberlain, PhD